ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2195

Pediatric Rheumatology Graduation: A One-Way Bridge to Adult Care?

Kyla Fergason1, David McDonald1, Karissa Chesky2, Jimin Kim2, Tiphanie Vogel1 and Miriah Gillispie-Taylor3, 1Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Houston, 3Baylor College of Medicine/Texas Children's Hospital, Houston, TX

Meeting: ACR Convergence 2024

Keywords: Pediatric rheumatology, quality of care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Pediatric Rheumatology – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: For many patients with childhood onset disease, the transition from pediatric to adult healthcare is difficult, often resulting in lapses in care and increased disease activity and morbidity. Texas Children’s Hospital pediatric rheumatology clinic has instituted measures to improve preparedness for transfer to adult rheumatology including introduction of a policy, tracking eligible patients, using a transition planning tool, and self-assessment of preparedness. We have instituted a formal acknowledgment for patients at the last pediatric visit to emphasize the care transfer event, which includes finalization of a transition summary letter given to the patient to help prevent loss of information when establishing care with adult rheumatology.

Methods: Emails were sent to providers, initially biweekly then weekly, identifying all transition-age patients and reminding providers to discuss transition from February 2023 to April 2024. Those ages 17 and older were emphasized due to their more imminent transfer of care to adult rheumatology. Retrospective review of the electronic health record (EHR) was used to assess transition status. Patients were grouped by those who had a scheduled appointment with an adult rheumatologist and a transition summary letter, those whose pediatric provider identified the visit as the final pediatric visit but did not create a transition summary letter, and those for whom specific transfer of care was still pending.  We also tracked whether the provider documented discussing transition. We aimed to acknowledge at least 90% of patients transitioning from rheumatology clinic to adult healthcare, marked by a transition summary letter, between February 2023 to April 2024.

Results: From February 2023 to April 2024, 1151 potential final pediatric visits were identified, 733 (63.7%) of notes documented discussion of transition at the visit, and a total of 127 patients were identified as ready to transition. Of those, 91 patients (71.6%) received a summary letter.

Conclusion: During the transition from pediatric to adult care, many patients experience flares and lapses in care. We continue to build on transition pathway work conducted within pediatric rheumatology in order to help provide a sense of closure and consolidate information for adult providers. 71.6% of eligible patients have received a transition summary since the institution of this initiative, which should help prevent loss of information between providers. We aim to continue to follow patients longitudinally to assess the impact of this intervention on the successful transfer of care.


Disclosures: K. Fergason: None; D. McDonald: None; K. Chesky: None; J. Kim: None; T. Vogel: AstraZeneca, 5, Moderna, 2, Pfizer, 2, SOBI, 2; M. Gillispie-Taylor: None.

To cite this abstract in AMA style:

Fergason K, McDonald D, Chesky K, Kim J, Vogel T, Gillispie-Taylor M. Pediatric Rheumatology Graduation: A One-Way Bridge to Adult Care? [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/pediatric-rheumatology-graduation-a-one-way-bridge-to-adult-care/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pediatric-rheumatology-graduation-a-one-way-bridge-to-adult-care/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology